Kraig Biocraft Laboratories (KBLB) Non-Current Debt (2010 - 2023)

Kraig Biocraft Laboratories has disclosed Non-Current Debt across 9 years of filings, most recently posting $6.3 million for Q3 2023.

• In Q3 2023, Non-Current Debt rose 5336.84% year-over-year to $6.3 million; the TTM figure through Sep 2023 stood at $6.3 million (up 5336.84% YoY), while the FY2022 annual figure was $5.7 million, up 5900.39% from the prior year.
• Non-Current Debt came in at $6.3 million for Q3 2023 at Kraig Biocraft Laboratories, up from $6.0 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $6.3 million in Q3 2023 to a low of $95244.0 in Q4 2021.
• Average Non-Current Debt over 5 years is $1.4 million, with a median of $155244.0 recorded in 2020.
• Year-over-year, Non-Current Debt tumbled 34.42% in 2021 and jumped 5900.39% in 2022.
• Over 5 years, Non-Current Debt stood at $185244.0 in 2019, then fell by 21.59% to $145244.0 in 2020, then slumped by 34.42% to $95244.0 in 2021, then jumped by 5900.39% to $5.7 million in 2022, then gained by 9.63% to $6.3 million in 2023.
• Per Business Quant data, the three most recent Non-Current Debt figures were $6.3 million in Q3 2023, $6.0 million in Q2 2023, and $5.8 million in Q1 2023.